{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:33:26Z","timestamp":1762252406082,"version":"3.37.3"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.leukres.2016.06.011","type":"journal-article","created":{"date-parts":[[2016,7,3]],"date-time":"2016-07-03T03:56:51Z","timestamp":1467518211000},"page":"26-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Reversine triggers mitotic catastrophe and apoptosis in K562 cells"],"prefix":"10.1016","volume":"48","author":[{"given":"Ana Paula Nunes","family":"Rodrigues Alves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Agostinho","family":"Machado-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila Santos","family":"Scheucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helder Henrique","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belinda Pinto","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1567-4086","authenticated-orcid":false,"given":"Eduardo Magalh\u00e3es","family":"Rego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Traina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2016.06.011_bib0005","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"Druker","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.06.011_bib0010","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.clml.2015.03.006","article-title":"Use of second- and third-generation tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia: an evolving treatment paradigm","volume":"15","author":"Jabbour","year":"2015","journal-title":"Clin. Lymphoma Myeloma Leukemia"},{"key":"10.1016\/j.leukres.2016.06.011_bib0015","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/ijc.28434","article-title":"Bcr-Abl activates AURKA and AURKB in chronic myeloid leukemia cells via AKT signaling","volume":"134","author":"Yang","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.leukres.2016.06.011_bib0020","doi-asserted-by":"crossref","first-page":"742","DOI":"10.14740\/jocmr2295w","article-title":"Aurora kinases and potential medical applications of aurora kinase inhibitors: a review","volume":"7","author":"Gavriilidis","year":"2015","journal-title":"J. Clin. Med. Res."},{"key":"10.1016\/j.leukres.2016.06.011_bib0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1586\/14737140.6.1.109","article-title":"Aurora A and B kinases as targets for cancer: will they be selective for tumors?","volume":"6","author":"Matthews","year":"2006","journal-title":"Expert Rev. Anticancer. Ther."},{"key":"10.1016\/j.leukres.2016.06.011_bib0030","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-07-0067","article-title":"A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia","volume":"6","author":"Ikezoe","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.leukres.2016.06.011_bib0035","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3324\/haematol.2011.055681","article-title":"Marked upregulation of Survivin and Aurora-B kinase is associated with disease progression in the myelodysplastic syndromes","volume":"97","author":"Yoshida","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2016.06.011_bib0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/carcin\/bgr278","article-title":"Overcoming CML acquired resistance by specific inhibition of Aurora A kinase in the KCL-22 cell model","volume":"33","author":"Yuan","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.leukres.2016.06.011_bib0045","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1111\/j.1582-4934.2010.01218.x","article-title":"The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib","volume":"15","author":"Kelly","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.leukres.2016.06.011_bib0050","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bcp.2009.10.009","article-title":"Targets and effectors of the cellular response to Aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemia","volume":"79","author":"Donato","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.leukres.2016.06.011_bib0055","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.leukres.2008.04.012","article-title":"PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases","volume":"32","author":"Gontarewicz","year":"2008","journal-title":"Leukemia Res."},{"key":"10.1016\/j.leukres.2016.06.011_bib0060","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1182\/blood-2007-09-113175","article-title":"Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I","volume":"111","author":"Gontarewicz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.06.011_bib0065","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/1535-7163.MCT-07-2051","article-title":"Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells","volume":"7","author":"D'Alise","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.leukres.2016.06.011_bib0070","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.4161\/cc.20621","article-title":"Preferential killing of p53-deficient cancer cells by reversine","volume":"11","author":"Jemaa","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.leukres.2016.06.011_bib0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1423-0127-19-9","article-title":"Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy","volume":"19","author":"Lee","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.leukres.2016.06.011_bib0080","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nm.2112","article-title":"Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity","volume":"16","author":"McMillin","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.leukres.2016.06.011_bib0085","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12282-012-0400-z","article-title":"Reversine induces cell cycle arrest, polyploidy, and apoptosis in human breast cancer cells","volume":"21","author":"Kuo","year":"2014","journal-title":"Breast Cancer"},{"key":"10.1016\/j.leukres.2016.06.011_bib0090","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.biopha.2012.08.001","article-title":"Autophagy induction of reversine on human follicular thyroid cancer cells","volume":"66","author":"Lu","year":"2012","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.leukres.2016.06.011_bib0095","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/jcb.24197","article-title":"The synthetic purine reversine selectively induces cell death of cancer cells","volume":"113","author":"Piccoli","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.leukres.2016.06.011_bib0100","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.leukres.2016.06.011_bib0105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0092-8674(00)00034-9","article-title":"Mitotic phosphorylation of histone H3 is governed by Ipl1\/aurora kinase and Glc7\/PP1 phosphatase in budding yeast and nematodes","volume":"102","author":"Hsu","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2016.06.011_bib0110","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.4161\/15384101.2014.946852","article-title":"Bimodal regulation of p21(waf1) protein as function of DNA damage levels","volume":"13","author":"Buscemi","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.leukres.2016.06.011_bib0115","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1038\/sj.onc.1208474","article-title":"Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities","volume":"24","author":"He","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2016.06.011_bib0120","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.282.5393.1497","article-title":"Requirement for p53 and p21 to sustain G2 arrest after DNA damage","volume":"282","author":"Bunz","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.leukres.2016.06.011_bib0125","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ncomms2091","article-title":"Insights into the biomedical effects of carboxylated single-wall carbon nanotubes on telomerase and telomeres","volume":"3","author":"Chen","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.leukres.2016.06.011_bib0130","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrm1245","article-title":"The cellular geography of aurora kinases","volume":"4","author":"Carmena","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.leukres.2016.06.011_bib0135","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1038\/sj.onc.1207528","article-title":"Cell death by mitotic catastrophe: a molecular definition","volume":"23","author":"Castedo","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2016.06.011_bib0140","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s12035-015-9139-9","article-title":"Inhibitor of Aurora kinase B induces differentially cell death and polyploidy via DNA damage response pathways in neurological malignancy: shedding new light on the challenge of resistance to AZD1152-HQPA","volume":"53","author":"Zekri","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.leukres.2016.06.011_bib0145","doi-asserted-by":"crossref","first-page":"9327","DOI":"10.18632\/oncotarget.3313","article-title":"Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.leukres.2016.06.011_bib0150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12967-015-0385-4","article-title":"Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy","volume":"13","author":"Porcelli","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.leukres.2016.06.011_bib0155","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.4161\/cc.8.19.9729","article-title":"The aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe","volume":"8","author":"Tao","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.leukres.2016.06.011_bib0160","doi-asserted-by":"crossref","first-page":"e104279","DOI":"10.1371\/journal.pone.0104279","article-title":"A novel ATM\/TP53\/p21-mediated checkpoint only activated by chronic gamma-irradiation","volume":"9","author":"Cao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2016.06.011_bib0165","doi-asserted-by":"crossref","first-page":"e112318","DOI":"10.1371\/journal.pone.0112318","article-title":"Inhibition of Aurora kinase B is important for biologic activity of the dual inhibitors of BCR-ABL and Aurora kinases R763\/AS703569 and PHA-739358 in BCR-ABL transformed cells","volume":"9","author":"Illert","year":"2014","journal-title":"PLoS One"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616301436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616301436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T12:01:58Z","timestamp":1620993718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212616301436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":33,"alternative-id":["S0145212616301436"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2016.06.011","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversine triggers mitotic catastrophe and apoptosis in K562 cells","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2016.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}